175 related articles for article (PubMed ID: 21585385)
1. Suppression of inflammatory response and endothelial nitric oxide synthase downregulation in hyperlipidaemic C57BL/6J mice by eugenosedin-A.
Shen KP; Lin HL; Chang WT; An LM; Chen IJ; Wu BN
J Pharm Pharmacol; 2011 Jun; 63(6):860-8. PubMed ID: 21585385
[TBL] [Abstract][Full Text] [Related]
2. Eugenosedin-A prevents hyperglycaemia, hyperlipidaemia and lipid peroxidation in C57BL/6J mice fed a high-fat diet.
Shen KP; Lin HL; Hsieh SL; Kwan AL; Chen IJ; Wu BN
J Pharm Pharmacol; 2009 Apr; 61(4):517-25. PubMed ID: 19298700
[TBL] [Abstract][Full Text] [Related]
3. Eugenosedin-A prevents high-fat diet increased adhesion molecules through inhibition of MAPK- and p65-mediated NF-κB pathway in rat model.
Lin HL; Shen KP; Chang WT; Lin JC; An LM; Chen IJ; Wu BN
J Pharm Pharmacol; 2013 Feb; 65(2):300-9. PubMed ID: 23278698
[TBL] [Abstract][Full Text] [Related]
4. Eugenosedin-A amelioration of lipopolysaccharide-induced up-regulation of p38 MAPK, inducible nitric oxide synthase and cyclooxygenase-2.
Shen KP; Liou SF; Hsieh SL; Chen IJ; Wu BN
J Pharm Pharmacol; 2007 Jun; 59(6):879-89. PubMed ID: 17637181
[TBL] [Abstract][Full Text] [Related]
5. Anti-inflammatory effects of Scutellaria baicalensis extract via suppression of immune modulators and MAP kinase signaling molecules.
Kim EH; Shim B; Kang S; Jeong G; Lee JS; Yu YB; Chun M
J Ethnopharmacol; 2009 Nov; 126(2):320-31. PubMed ID: 19699788
[TBL] [Abstract][Full Text] [Related]
6. Atorvastatin restores the impaired vascular endothelium-dependent relaxations mediated by nitric oxide and endothelium-derived hyperpolarizing factors but not hypotension in sepsis.
Subramani J; Kathirvel K; Leo MD; Kuntamallappanavar G; Uttam Singh T; Mishra SK
J Cardiovasc Pharmacol; 2009 Dec; 54(6):526-34. PubMed ID: 19755915
[TBL] [Abstract][Full Text] [Related]
7. Bryostatin-1 and IFN-gamma synergize for the expression of the inducible nitric oxide synthase gene and for nitric oxide production in murine macrophages.
Taylor LS; Cox GW; Melillo G; Bosco MC; Espinoza-Delgado I
Cancer Res; 1997 Jun; 57(12):2468-73. PubMed ID: 9192827
[TBL] [Abstract][Full Text] [Related]
8. Atorvastatin protects obese mice against hepatic ischemia-reperfusion injury by Toll-like receptor-4 suppression and endothelial nitric oxide synthase activation.
Ajamieh H; Farrell G; Wong HJ; Yu J; Chu E; Chen J; Teoh N
J Gastroenterol Hepatol; 2012 Aug; 27(8):1353-61. PubMed ID: 22432744
[TBL] [Abstract][Full Text] [Related]
9. NCX 6560, a nitric oxide-releasing derivative of atorvastatin, inhibits cholesterol biosynthesis and shows anti-inflammatory and anti-thrombotic properties.
Momi S; Impagnatiello F; Guzzetta M; Caracchini R; Guglielmini G; Olivieri R; Monopoli A; Gresele P
Eur J Pharmacol; 2007 Sep; 570(1-3):115-24. PubMed ID: 17632098
[TBL] [Abstract][Full Text] [Related]
10. Potential role of the JNK/SAPK signal transduction pathway in the induction of iNOS by TNF-alpha.
Chan ED; Riches DW
Biochem Biophys Res Commun; 1998 Dec; 253(3):790-6. PubMed ID: 9918806
[TBL] [Abstract][Full Text] [Related]
11. Chronic physiological shear stress inhibits tumor necrosis factor-induced proinflammatory responses in rabbit aorta perfused ex vivo.
Yamawaki H; Lehoux S; Berk BC
Circulation; 2003 Sep; 108(13):1619-25. PubMed ID: 12963644
[TBL] [Abstract][Full Text] [Related]
12. Antioxidant eugenosedin-A protects against lipopolysaccharide-induced hypotension, hyperglycaemia and cytokine immunoreactivity in rats and mice.
Shen KP; Lo YC; Yang RC; Liu HW; Chen IJ; Wu BN
J Pharm Pharmacol; 2005 Jan; 57(1):117-25. PubMed ID: 15639000
[TBL] [Abstract][Full Text] [Related]
13. Diosgenin inhibits macrophage-derived inflammatory mediators through downregulation of CK2, JNK, NF-kappaB and AP-1 activation.
Jung DH; Park HJ; Byun HE; Park YM; Kim TW; Kim BO; Um SH; Pyo S
Int Immunopharmacol; 2010 Sep; 10(9):1047-54. PubMed ID: 20601188
[TBL] [Abstract][Full Text] [Related]
14. Atorvastatin attenuates mitochondrial toxin-induced striatal degeneration, with decreasing iNOS/c-Jun levels and activating ERK/Akt pathways.
Lee ST; Chu K; Park JE; Hong NH; Im WS; Kang L; Han Z; Jung KH; Kim MW; Kim M
J Neurochem; 2008 Mar; 104(5):1190-200. PubMed ID: 17976163
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of inducible nitric-oxide synthase expression by (5R)-5-hydroxytriptolide in interferon-gamma- and bacterial lipopolysaccharide-stimulated macrophages.
Zhou R; Zheng SX; Tang W; He PL; Li XY; Yang YF; Li YC; Geng JG; Zuo JP
J Pharmacol Exp Ther; 2006 Jan; 316(1):121-8. PubMed ID: 16166270
[TBL] [Abstract][Full Text] [Related]
16. Regulation of inducible nitric oxide synthase messenger RNA expression and nitric oxide production by lipopolysaccharide in vivo: the roles of macrophages, endogenous IFN-gamma, and TNF receptor-1-mediated signaling.
Salkowski CA; Detore G; McNally R; van Rooijen N; Vogel SN
J Immunol; 1997 Jan; 158(2):905-12. PubMed ID: 8993010
[TBL] [Abstract][Full Text] [Related]
17. Complementary roles of tumor necrosis factor alpha and interferon gamma in inducible microglial nitric oxide generation.
Mir M; Tolosa L; Asensio VJ; Lladó J; Olmos G
J Neuroimmunol; 2008 Nov; 204(1-2):101-9. PubMed ID: 18703234
[TBL] [Abstract][Full Text] [Related]
18. Isoprenoid depletion by statins antagonizes cytokine-induced down-regulation of endothelial nitric oxide expression and increases NO synthase activity in human umbilical vein endothelial cells.
Jantzen F; Könemann S; Wolff B; Barth S; Staudt A; Kroemer HK; Dahm JB; Felix SB; Landsberger M
J Physiol Pharmacol; 2007 Sep; 58(3):503-14. PubMed ID: 17928646
[TBL] [Abstract][Full Text] [Related]
19. Atorvastatin inhibition of cytokine-inducible nitric oxide synthase expression in native endothelial cells in situ.
Wagner AH; Schwabe O; Hecker M
Br J Pharmacol; 2002 May; 136(1):143-9. PubMed ID: 11976279
[TBL] [Abstract][Full Text] [Related]
20. Roles of tyrosine kinases in the regulation of nitric oxide synthesis in murine liver cells: modulation of NF-kappa B activity by tyrosine kinases.
Lee BS; Kang HS; Pyun KH; Choi I
Hepatology; 1997 Apr; 25(4):913-9. PubMed ID: 9096597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
